(Q30396047)

21 June 2017

title

Development and strategies of cell-culture technology for influenza vaccine (English)

1 reference

21 June 2017

1 reference

Shao-Zhen Feng

1

1 reference

21 June 2017

Pei-Rong Jiao

2

1 reference

21 June 2017

Wen-Bao Qi

3

1 reference

21 June 2017

Hui-Ying Fan

4

1 reference

21 June 2017

Ming Liao

5

1 reference

21 June 2017

language of work or name

English

0 references

publication date

10 November 2010

1 reference

Applied Microbiology and Biotechnology

21 June 2017

published in

1 reference

21 June 2017

volume

89

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

893-902

1 reference

The role of p21cip1 in adaptation of CHO cells to suspension and protein-free culture

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Molecular characterization of three recombinant isolates of avian leukosis virus obtained from contaminated Marek's disease vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Development and use of fowlpox vectored vaccines for avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Development and application of avian influenza vaccines in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Strategies for broad global access to pandemic influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Growth inhibition in animal cell culture. The effect of lactate and ammonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Different progress of MDCK cell death after infection by two different influenza virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Activation of influenza A viruses by trypsin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Inflexal V--the influenza vaccine with the lowest ovalbumin content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Cytopathogenesis and inhibition of host gene expression by RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Metabolic active-high density VERO cell cultures on microcarriers following apoptosis prevention by galactose/glutamine feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Mathematical model of influenza A virus production in large-scale microcarrier culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Role of neuraminidase in influenza virus-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Host factors for replication and transcription of the influenza virus genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Influenza virus morphogenesis and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Suspension-Vero cell cultures as a platform for viral vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Live cold-adapted influenza A vaccine produced in Vero cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Evidence for host-cell selection of influenza virus antigenic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Structured model of influenza virus replication in MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

THE PREPARATION AND PROPERTIES OF INFLUENZA VIRUS VACCINES CONCENTRATED AND PURIFIED BY DIFFERENTIAL CENTRIFUGATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Pluronic enhances the robustness and reduces the cell attachment of mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Modelling HA protein-mediated interaction between an influenza virus and a healthy cell: pre-fusion membrane deformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Metabolic flux model for an anchorage-dependent MDCK cell line: characteristic growth phases and minimum substrate consumption flux distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

In vitro assessment of the allergenicity of a novel influenza vaccine produced in dog kidney cells in individuals with dog allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Protection against influenza virus challenge by topical application of influenza DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Reactions of antibodies with surface antigens of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

Experimental infection with avian leukosis virus isolated from Marek's disease vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-010-2973-9

10.1007/S00253-010-2973-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1003868924

0 references

1 reference